Related Posts
FDA approves Cobenfy: A breakthrough Schizophrenia treatment after decades
The US FDA has approved Bristol Myers Squibb’s oral medicine, Cobenfy, for treating schizophrenia in adults. This is the first new type of medication in […]
Chandra: Tata Group’s green shift painful but necessary
Tata Group is shifting towards green businesses and semiconductor manufacturing to secure its future, as stated by chairman N Chandrasekaran. This involves closing blast furnaces […]
WHO’s 1 doctor per 1,000 people reality by 2030
- staff
- February 1, 2025
- 0
India is on track to meet the WHO recommendation of one doctor per 1,000 people by 2030, currently having a ratio of 1:1,263. This target […]